The value of endomyocardial biopsy in diagnosis and guiding therapy.

[1]  G. Thiene,et al.  Diagnostic use of the endomyocardial biopsy: a consensus statement , 2013, Virchows Archiv.

[2]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[3]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[4]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[5]  G. Thiene,et al.  Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders , 2003, Circulation.

[6]  S. Packman,et al.  Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy , 2003, Annals of Internal Medicine.

[7]  G. Berry,et al.  The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. , 2002, Journal of cardiac failure.

[8]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[9]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[10]  R. Hruban,et al.  The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. , 1999, Medicine.

[11]  G. Berry,et al.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[12]  W. Abelmann,et al.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. , 1992, The American journal of cardiology.

[13]  K. Sell,et al.  Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. , 1990, Journal of the American College of Cardiology.

[14]  A. J. Hauck,et al.  Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. , 1989, Mayo Clinic proceedings.

[15]  B. McManus,et al.  Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. , 1989, Journal of the American College of Cardiology.

[16]  J. Lie.  Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease. , 1988, Annals of internal medicine.

[17]  S. Konno,et al.  ENDO-MYOCARDIAL BIOPSY. , 1963, Diseases of the chest.